Oramed Pharmaceuticals Inc.
$4.105
USD
Last updated on --.
24h volume32.46K
24h highest4.1290 USD
24h lowest3.8910 USD
24h Price movement+1.61%
ORMP recent prices
24 Hours
+1.61%+$0.065
30 days
-1.82%-$0.075
60 days
+20.69%+$0.685
90 days
+17.64%+$0.605
Key data
Previous close4.0400 USD
Market cap173.11M USD
Volume32.46K
P/E ratio2.740000
Dividend yield (TTM)0.00%
Dividend amount0.25000 USD
Next ex-dividend dateJan 16, 2026
Next payment dateJan 26, 2026
EPS diluted (TTM)1.5600 USD
Net income (FY)64.02M USD
Revenue (FY)2.00M USD
Last report dateMar 26, 2026
About Oramed Pharmaceuticals Inc.
HeadquartersNEW YORK
Employees (FY)13.00
Revenue per employee (FY)153.85K USD
Net income per employee (FY)4.92M USD
Listed onNasdaq
ORMP conversion tables
 |  |
|---|---|
| 0.5 ORMP | 2.052 USD |
| 1 ORMP | 4.105 USD |
| 5 ORMP | 20.52 USD |
| 10 ORMP | 41.05 USD |
| |
|---|---|
| 0.5 USD | 0.1218 ORMP |
| 1 USD | 0.24361 ORMP |
| 5 USD | 1.218 ORMP |
| 10 USD | 2.436 ORMP |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ORMP is trading at $4.105, +1.61% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ORMP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ORMP is currently trading at $4.105, +1.61% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ORMP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ORMP's P/E ratio is currently 2.740000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ORMP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ORMP's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Oramed Pharmaceuticals Inc.'s market cap is currently 173.11M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume32.46K
24h highest4.1290 USD
24h lowest3.8910 USD
24h Price movement+1.61%
Start trade with ORMP Perpetual
Sign up to trade